Biotech

All Articles

Analysts dig into Avidity's DMD succeed, disclosing subtleties in records

.Avidity Biosciences impressed financiers along with stage 1/2 records in Duchenne muscular dystroph...

Actinogen's cortisol blocker stops working phase 2 clinical depression study

.Actinogen Medical's cortisol blocker has actually overlooked the main endpoint of a period 2 resear...

Bivictrix chooses going private only way to take ADC into clinic

.Antibody-drug conjugates (ADCs) have actually gone to the facility of lots of a billion-dollar biob...

TPG tops up funds to $580M for assets around life sciences

.Possession supervisor TPG, which has assisted biotechs like Sionna Therapies and also Santa Ana Bio...

Merck stops stage 3 TIGIT test in lung cancer for futility

.Merck &amp Co.'s TIGIT system has gone through an additional trouble. Months after shuttering a pha...

After a difficult year, Exscientia folds up into Recursion

.After a year determined by pipeline cuts, the departure of its chief executive officer and layoffs,...

Cullinan, after $25M deal, hands back bispecific to Port

.Cullinan Therapy was actually wowed good enough along with Harbour BioMed's bispecific immune syste...

A better examine Fierce Biotech's Ferocious 15

.In this week's episode of "The Leading Line," our team're diving into Strong Biotech's yearly Fierc...

Lilly encounters period 2 failing of tau-targeting med

.The confetti is actually still soaring from Eli Lilly's party celebrating the approval of Alzheimer...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings and...